Nirmatrelvir/ritonavir for patients with SARS-CoV-2 infection and impaired kidney function during the Omicron surge

• Main Authors: Jiayi Yan (Author), Hong Cai (Author), Jieying Wang (Author), Mingli Zhu (Author), Ping Li (Author), Peiying Li (Author), Bin Wu (Author), Xiajing Che (Author), Leyi Gu (Author), Shan Mou (Author)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2023-03-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Background: Nirmatrelvir/ritonavir has demonstrated effectiveness in high-risk patients with coronavirus disease 2019 (COVID-19). However, investigations on the efficacy and safety of nirmatrelvir/ritonavir in patients with kidney dysfunction are limited.Methods: Data were collected from the patient...